Xuebei An

675 total citations
8 papers, 79 citations indexed

About

Xuebei An is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Xuebei An has authored 8 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Xuebei An's work include Advanced Breast Cancer Therapies (3 papers), Brain Metastases and Treatment (3 papers) and Thyroid and Parathyroid Surgery (2 papers). Xuebei An is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Brain Metastases and Treatment (3 papers) and Thyroid and Parathyroid Surgery (2 papers). Xuebei An collaborates with scholars based in United States, Canada and Germany. Xuebei An's co-authors include Dolores Shoback, Lars Rejnmark, Christopher T. Sibley, B.L. Clarke, Lynn Kohlmeier, Tamara Vokes, Aimee D Shu, Claudia Gagnon, Aliya Khan and Andrea Palermo and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Xuebei An

7 papers receiving 77 citations

Peers

Xuebei An
Jennifer Cannon United States
Xuebei An
Citations per year, relative to Xuebei An Xuebei An (= 1×) peers Jennifer Cannon

Countries citing papers authored by Xuebei An

Since Specialization
Citations

This map shows the geographic impact of Xuebei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebei An more than expected).

Fields of papers citing papers by Xuebei An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuebei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebei An. The network helps show where Xuebei An may publish in the future.

Co-authorship network of co-authors of Xuebei An

This figure shows the co-authorship network connecting the top 25 collaborators of Xuebei An. A scholar is included among the top collaborators of Xuebei An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuebei An. Xuebei An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Clarke, B.L., Aliya Khan, Mishaela R. Rubin, et al.. (2024). Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial. The Journal of Clinical Endocrinology & Metabolism. 110(4). 951–960. 11 indexed citations
3.
Wardley, Andrew, Volkmar Mueller, Elisavet Paplomata, et al.. (2021). Abstract PD13-04: Impact of tucatinib on health-related quality of life in patients with HER2+ metastatic breast cancer with stable and active brain metastases. Cancer Research. 81(4_Supplement). PD13–4. 3 indexed citations
4.
Mueller, Volkmar, Erika Hamilton, Amelia Zelnak, et al.. (2020). 275O Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM). Annals of Oncology. 31. S349–S350. 4 indexed citations
5.
Khan, Aliya, Mishaela R. Rubin, Peter Schwarz, et al.. (2020). Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. Journal of Bone and Mineral Research. 38(1). 14–25. 47 indexed citations
6.
Lin, Nancy U., Rashmi K. Murthy, Carey K. Anders, et al.. (2020). 53. TUCATINIB VS PLACEBO ADDED TO TRASTUZUMAB AND CAPECITABINE FOR PATIENTS WITH PREVIOUSLY TREATED HER2+ METASTATIC BREAST CANCER (MBC) WITH BRAIN METASTASES (BM) (HER2CLIMB). Neuro-Oncology Advances. 2(Supplement_2). ii11–ii11. 1 indexed citations
7.
Rose, Johnie, Knut Magne Augestad, Chung Yin Kong, et al.. (2014). A simulation model of colorectal cancer surveillance and recurrence. BMC Medical Informatics and Decision Making. 14(1). 29–29. 11 indexed citations
8.
Seicean, Sinziana, Kazuaki Negishi, Tomoko Negishi, et al.. (2012). OBSTRUCTIVE SLEEP APNEA AND ASTHMA CO-MORBIDITIES ARE INDEPENDENT PREDICTORS OF NEW HEART FAILURE AND ATRIAL FIBRILLATION IN PATIENTS WITH DIABETES MELLITUS AND PRESERVED EJECTION FRACTION. Journal of the American College of Cardiology. 59(13). E1048–E1048. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026